Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ying Luo currently holds 2,565,226 shares of GYRE THERAPEUTICS, INC. (GYRE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ying Luo has been a net seller of GYRE stock. They have purchased $0 and sold $82.9K worth of shares.
Ying Luo's most recent insider trade was on May 6, 2026, when they sold 10,136 shares at $8.04 per share.
Ying Luo serves as Executive at GYRE THERAPEUTICS, INC. (GYRE). They have executed 4 insider transactions totaling $82.9K over their tenure at the company.
Ying Luo holds the position of Executive at GYRE THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Ying Luo has shown a selling trading pattern, with $0 in total purchases and $82.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ying Luo was on May 6, 2026, when they sold $81.5K worth of GYRE shares. This transaction involved 10,136 shares at $8.04 per share.
Ying Luo currently owns 2,565,226 shares of GYRE THERAPEUTICS, INC. (GYRE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ying Luo's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ying Luo has 4 Form 4 filings on record as an insider at GYRE THERAPEUTICS, INC..
Set alerts for Ying Luo and 40,000+ other insiders.